SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Harvard Scientific (HVSF)Hot$$- male impotency medicine -- Ignore unavailable to you. Want to Upgrade?


To: RT who wrote (3168)2/7/1998 11:33:00 PM
From: Batman  Respond to of 3906
 
..............atomic batteries to power..............turbines to speed.............

This is Batman.

RT,

You have hit it on the head when you stated, "Nothing will prevent HVSF from getting FDA approval for their product. It's when they attempt to sell the product that Vivus will file a patent infringement."

But what you and everybody else doesn't understand is that BY THAT TIME HARVARD SCIENTIFIC'S BOARD WILL HAVE SOLD OUT THEIR SHARES LIKE THEY DID LAST YEAR.

RT, you concentrate on the wrong thing. The product isn't important. What is important is where the investors' money goes, and who has it. In See's/Waites's minds it's got nothing to do with rubbish like "FDA approval" and what not that you speak of. The point is: by the time that you realise that they have your money, it is too late, and although you will express rightous indignation, your lawyer will inform you that the costs of recovery outweigh the probabilities of recovering anything. Wake up! Do I have to teach you the facts of life? Jesus. What a post from you. I expected better.

Batman

P.S.--Actually, your post was one of the better technical posts in recent memory. But I don't think very many people will cotton on. And so it goes . . .



To: RT who wrote (3168)2/8/1998 3:21:00 AM
From: Afaq Sarwar  Read Replies (2) | Respond to of 3906
 
RT,

I hope that Mr. Batman will not be too angry at us for discussing this product thing again. Apparently, he would rather have us discuss some bad guy who was on HVSFD board years ago and was subsequently kicked out, or he would rather have us discuss this cell phone guy from London.

In any case, the HVSFD patent covers both the drug as well as the delivery system. And I believe that the HVSFD delivery system does not infringe on Gene Voss's patent for delivery system. VVUS has the rights to the Gene Voss's patent.

At this point we both can argue endlessly about this. However, as I understand, the HVSFD patent will become a public document on or around Feb. 18, 1998. Gene Voss's patent can already be viewed on the internet. Once you review both of these patents, you can decide for yourself.

So, not only this car has wheel, it apparently has some high performance one.

Also, looks like that it will not come to a point where VVUS may have to file a patent infringement court action. HVSFD has already initiated a court action requesting for a declaratory judgment that will have this issue addressed much sooner than the final FDA approval. It is my understanding that the VVUS attorneys with $100 million to spend are relying at the moment on "motions for continuance" to support their case. Does not look too good for them.

I do grant that in any legal proceeding there is always a possibility of an unexpected outcome for either party. Since you don't own any shares of HVSFD, that is some thing you do not have to worry about.

Regards.

Afaq Sarwar